BioGaia AB Valuation
| BIOG-B Stock | SEK 105.80 1.10 1.05% |
At this time, the firm appears to be overvalued. BioGaia AB shows a prevailing Real Value of kr89.99 per share. The current price of the firm is kr105.8. Our model approximates the value of BioGaia AB from analyzing the firm fundamentals such as Current Valuation of 7.35 B, return on equity of 0.19, and Profit Margin of 0.34 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BioGaia AB's price fluctuation is very steady at this time. Calculation of the real value of BioGaia AB is based on 3 months time horizon. Increasing BioGaia AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BioGaia AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioGaia Stock. However, BioGaia AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 105.8 | Real 89.99 | Hype 105.8 | Naive 100.89 |
The real value of BioGaia Stock, also known as its intrinsic value, is the underlying worth of BioGaia AB Company, which is reflected in its stock price. It is based on BioGaia AB's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BioGaia AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BioGaia AB helps investors to forecast how BioGaia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioGaia AB more accurately as focusing exclusively on BioGaia AB's fundamentals will not take into account other important factors: BioGaia AB Total Value Analysis
BioGaia AB is currently estimated to have takeover price of 7.35 B with market capitalization of 10.57 B, debt of 10.4 M, and cash on hands of 1.48 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BioGaia AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.35 B | 10.57 B | 10.4 M | 1.48 B |
BioGaia AB Investor Information
About 50.0% of the company shares are held by institutions such as insurance companies. The book value of BioGaia AB was currently reported as 19.53. The company has Price/Earnings To Growth (PEG) ratio of 1.9. BioGaia AB last dividend was issued on the 9th of May 2022. The entity had 5:1 split on the 18th of May 2022. Based on the measurements of operating efficiency obtained from BioGaia AB's historical financial statements, BioGaia AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.BioGaia AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BioGaia AB has an asset utilization ratio of 49.86 percent. This suggests that the Company is making kr0.5 for each dollar of assets. An increasing asset utilization means that BioGaia AB is more efficient with each dollar of assets it utilizes for everyday operations.BioGaia AB Ownership Allocation
BioGaia AB holds a total of 97.28 Million outstanding shares. Over half of BioGaia AB's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in BioGaia AB. Please watch out for any change in the institutional holdings of BioGaia AB as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BioGaia AB Profitability Analysis
The company reported the revenue of 1.1 B. Net Income was 373.58 M with profit before overhead, payroll, taxes, and interest of 801.93 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BioGaia AB's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BioGaia AB and how it compares across the competition.
About BioGaia AB Valuation
The stock valuation mechanism determines BioGaia AB's current worth on a weekly basis. Our valuation model uses a comparative analysis of BioGaia AB. We calculate exposure to BioGaia AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioGaia AB's related companies.BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people.
8 Steps to conduct BioGaia AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BioGaia AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioGaia AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioGaia AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioGaia AB's revenue streams: Identify BioGaia AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioGaia AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioGaia AB's growth potential: Evaluate BioGaia AB's management, business model, and growth potential.
- Determine BioGaia AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioGaia AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for BioGaia Stock analysis
When running BioGaia AB's price analysis, check to measure BioGaia AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioGaia AB is operating at the current time. Most of BioGaia AB's value examination focuses on studying past and present price action to predict the probability of BioGaia AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioGaia AB's price. Additionally, you may evaluate how the addition of BioGaia AB to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |